Ditchcarbon
  • Contact
  1. Organizations
  2. Phastar
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated a month ago

Phastar Sustainability Profile

Company website

Phastar, a leading provider of statistical and data science services, is headquartered in Great Britain and operates across Europe and North America. Founded in 2015, the company has quickly established itself in the pharmaceutical and biotechnology sectors, offering innovative solutions in clinical trial data analysis and reporting. Phastar's core services include advanced statistical programming, data management, and regulatory submissions, distinguished by their commitment to quality and precision. The company has achieved significant milestones, including rapid growth and recognition for its expertise in delivering complex data solutions. With a strong market position, Phastar is known for its collaborative approach and deep understanding of regulatory requirements, making it a trusted partner for clients navigating the complexities of clinical development.

DitchCarbon Score

How does Phastar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Phastar's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

39%

Let us know if this data was useful to you

Phastar's reported carbon emissions

Phastar, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time. While there are no specific emissions figures to report, it is important to note that Phastar does not inherit emissions data from any parent organization, such as Amphastar Pharmaceuticals, Inc. This indicates that their climate strategy and emissions reporting are independent and not influenced by external corporate family relationships. As the industry increasingly prioritises sustainability, Phastar may consider developing measurable climate commitments and reduction initiatives to align with global standards and expectations.

How Carbon Intensive is Phastar's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Phastar's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Phastar's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Phastar is in GB, which has a very low grid carbon intensity relative to other regions.

Phastar's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Phastar has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Phastar's Emissions with Industry Peers

Halozyme Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Emergent BioSolutions

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Cipla USA Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Syneos Health

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Konecranes

FI
•
Machinery and equipment n.e.c. (29)
Updated 9 days ago

Par Pharmaceutical

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy